Cargando…

Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’

OBJECTIVES: To describe the development of the Claim Evaluation Tools, a set of flexible items to measure people's ability to assess claims about treatment effects. SETTING: Methodologists and members of the community (including children) in Uganda, Rwanda, Kenya, Norway, the UK and Australia....

Descripción completa

Detalles Bibliográficos
Autores principales: Austvoll-Dahlgren, Astrid, Semakula, Daniel, Nsangi, Allen, Oxman, Andrew David, Chalmers, Iain, Rosenbaum, Sarah, Guttersrud, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777467/
https://www.ncbi.nlm.nih.gov/pubmed/28515181
http://dx.doi.org/10.1136/bmjopen-2016-013184
_version_ 1783294201495027712
author Austvoll-Dahlgren, Astrid
Semakula, Daniel
Nsangi, Allen
Oxman, Andrew David
Chalmers, Iain
Rosenbaum, Sarah
Guttersrud, Øystein
author_facet Austvoll-Dahlgren, Astrid
Semakula, Daniel
Nsangi, Allen
Oxman, Andrew David
Chalmers, Iain
Rosenbaum, Sarah
Guttersrud, Øystein
author_sort Austvoll-Dahlgren, Astrid
collection PubMed
description OBJECTIVES: To describe the development of the Claim Evaluation Tools, a set of flexible items to measure people's ability to assess claims about treatment effects. SETTING: Methodologists and members of the community (including children) in Uganda, Rwanda, Kenya, Norway, the UK and Australia. PARTICIPANTS: In the iterative development of the items, we used purposeful sampling of people with training in research methodology, such as teachers of evidence-based medicine, as well as patients and members of the public from low-income and high-income countries. Development consisted of 4 processes: (1) determining the scope of the Claim Evaluation Tools and development of items; (2) expert item review and feedback (n=63); (3) cognitive interviews with children and adult end-users (n=109); and (4) piloting and administrative tests (n=956). RESULTS: The Claim Evaluation Tools database currently includes a battery of multiple-choice items. Each item begins with a scenario which is intended to be relevant across contexts, and which can be used for children (from age 10  and above), adult members of the public and health professionals. People with expertise in research methods judged the items to have face validity, and end-users judged them relevant and acceptable in their settings. In response to feedback from methodologists and end-users, we simplified some text, explained terms where needed, and redesigned formats and instructions. CONCLUSIONS: The Claim Evaluation Tools database is a flexible resource from which researchers, teachers and others can design measurement instruments to meet their own requirements. These evaluation tools are being managed and made freely available for non-commercial use (on request) through Testing Treatments interactive (testingtreatments.org). TRIAL REGISTRATION NUMBERS: PACTR201606001679337 and PACTR201606001676150; Pre-results.
format Online
Article
Text
id pubmed-5777467
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57774672018-01-29 Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’ Austvoll-Dahlgren, Astrid Semakula, Daniel Nsangi, Allen Oxman, Andrew David Chalmers, Iain Rosenbaum, Sarah Guttersrud, Øystein BMJ Open Patient-Centred Medicine OBJECTIVES: To describe the development of the Claim Evaluation Tools, a set of flexible items to measure people's ability to assess claims about treatment effects. SETTING: Methodologists and members of the community (including children) in Uganda, Rwanda, Kenya, Norway, the UK and Australia. PARTICIPANTS: In the iterative development of the items, we used purposeful sampling of people with training in research methodology, such as teachers of evidence-based medicine, as well as patients and members of the public from low-income and high-income countries. Development consisted of 4 processes: (1) determining the scope of the Claim Evaluation Tools and development of items; (2) expert item review and feedback (n=63); (3) cognitive interviews with children and adult end-users (n=109); and (4) piloting and administrative tests (n=956). RESULTS: The Claim Evaluation Tools database currently includes a battery of multiple-choice items. Each item begins with a scenario which is intended to be relevant across contexts, and which can be used for children (from age 10  and above), adult members of the public and health professionals. People with expertise in research methods judged the items to have face validity, and end-users judged them relevant and acceptable in their settings. In response to feedback from methodologists and end-users, we simplified some text, explained terms where needed, and redesigned formats and instructions. CONCLUSIONS: The Claim Evaluation Tools database is a flexible resource from which researchers, teachers and others can design measurement instruments to meet their own requirements. These evaluation tools are being managed and made freely available for non-commercial use (on request) through Testing Treatments interactive (testingtreatments.org). TRIAL REGISTRATION NUMBERS: PACTR201606001679337 and PACTR201606001676150; Pre-results. BMJ Publishing Group 2017-05-17 /pmc/articles/PMC5777467/ /pubmed/28515181 http://dx.doi.org/10.1136/bmjopen-2016-013184 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Patient-Centred Medicine
Austvoll-Dahlgren, Astrid
Semakula, Daniel
Nsangi, Allen
Oxman, Andrew David
Chalmers, Iain
Rosenbaum, Sarah
Guttersrud, Øystein
Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title_full Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title_fullStr Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title_full_unstemmed Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title_short Measuring ability to assess claims about treatment effects: the development of the ‘Claim Evaluation Tools’
title_sort measuring ability to assess claims about treatment effects: the development of the ‘claim evaluation tools’
topic Patient-Centred Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777467/
https://www.ncbi.nlm.nih.gov/pubmed/28515181
http://dx.doi.org/10.1136/bmjopen-2016-013184
work_keys_str_mv AT austvolldahlgrenastrid measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT semakuladaniel measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT nsangiallen measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT oxmanandrewdavid measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT chalmersiain measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT rosenbaumsarah measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools
AT guttersrudøystein measuringabilitytoassessclaimsabouttreatmenteffectsthedevelopmentoftheclaimevaluationtools